Standex price target raised to $205 from $175 at Roth Capital

Roth Capital raised the firm’s price target on Standex (SXI) to $205 from $175 and keeps a Buy rating on the shares. The company delivered a strong Q4 to cap off a transformational 2025, beating expectations on sales and adjusted EBITDA while producing 23% y/y sales growth and driving over 350bps of adjusted EBITDA margin expansion, the analyst tells investors in a research note. Electronics remains the standout segment for Standex, the firm added.